Chinese Journal of New Drugs 2012 Issue 16 Considerations for strengthening the supervision on clinical trials of vaccine in China(PartⅠ)

Considerations for strengthening the supervision on clinical trials of vaccine in China(PartⅠ)
GAO Rong;LI Jian-ming

..............page:1861-1863

Value of information analysis and cost-effectiveness threshold
ZONG Xin;SUN Li-hua

..............page:1836-1839

Compound sitagliptin-metformin:a new antidabetic agent for type 2 diabetes
ZHANG Rui-xue

..............page:1833-1835,1839

Technical requirement on nonclinical evaluation of fixed combinations from European Medicines Agency
GUANG Hong-mei;WANG Qing-li

..............page:1846-1848

Research advance of morinda officinalis oligosaccharides in treatment of depression
ZOU Lian-yong;ZHANG Hong-yan

..............page:1889-1891,1945

Comparative analysis of the innovative drug monitoring period system between China and Japan
DING Jin-xi;LI Yuan;WANG Ying-wei

..............page:1840-1845

Research advances in the gene polymorphisms of superoxide dismutase isoenzymes
WANG Zhan-qing;ZHAO Wei-juan;WANG Jin-ping

..............page:1884-1888,1907

Analysis and discussion on 2010 edition(volume I) of Chinese Pharmacopoeia
CAI Xiao-bing1;HU Xin2;JIN Peng-fei2

..............page:1874-1877

Efficacies of paliperidone extended-release tablets and olanzapine for treating schizophrenia in children and adolescents
XIE Qin;FENG Shao-hui;ZENG Hong-ling;XU yang;WANG Ji-zhong

..............page:1916-1919

Efficacy and safety of pregabalin in patients with post-herpetic neuralgia
GU Li-li;ZHANG Xue-xue;ZHANG Da-ying

..............page:1920-1922

Determination of geniposide and paeoniflorin in Jieyu Hegan capsules by HPLC
TAO Zhen-hua1;YANG Qing-sheng1;2;WANG Dan1;CHANG Li1;2

..............page:1939-1941

Optimization of the preparation process of anthraglucosennin pellets using Box-Behnken surface response design
PENG Shu-juan;WANG Ya-jing;ZHANG Wei-ling;WANG Yan-ming;PI Jia-xin;SUN Shi-zhen;TIAN Hui

..............page:1933-1938

Determination of donepoezil and its active metabolite 6-O-desmethyl donepezil in human plasma by HPLC-MS/MS method
CHEN Dan1;2;XIANG Jin1;YU Qin1;LIANG Mao-zhi1;NAN Feng1;QIN Yong-ping1

..............page:1912-1915

Clinical observation of compound Kushen injection combined with cisplatin and cisplatin alone in the treatment of malignant ascites
LIU Xun-yan;XIE Lin-hao;XV Jian-fang;YANG Hon-kai;ZHOU Lan

..............page:1923-1925

Determination of voriconazole in human plasma and saliva with LC-MS/MS
FENG Shi-yin;YONG Xiao-lan;DU Xiao-lin;LI Nan;HUANG Juan;WANG Lan-tian

..............page:1908-1911

The synthesis of anti-Alzheimer’s disease drug 2-hydroxy-5-[2-(4-trifluoro methyl-phenyl)-ethylamino]-benzoic acid
WU Yu-liang1;2;LU Xin2;CHEN Xiao-li2;ZHANG Xing-xian1

..............page:1930-1932

Progress of research on the treatment of thalassemia with iron chelators
HUANG Ming-hui;WANG Yun-long;LI Yong-shu

..............page:1900-1907

WINDOW OF NEW DRUGS

..............page:1831-1832

The experience of full pharmaceutical care in one patient with acute asthmatic bronchitis
SHI Jun-feng;XU Li;HAN Xu-liang;LONG Li-hui

..............page:1946-1949

Retrospective analysis of narcotic drug application during 2008-2011 in our hospital
SHI Yi

..............page:1950-1952

di 10 jie zhong guo guo ji xin yao chuang zhi qian yan ji shu yu chan ye hua fa zhan feng hui zuo xiang mu he zuo qia tan hui hui yi tong zhi

..............page:1845

Repeated dose toxicity study of recombinant human interleukin-12 in cynomolgus monkeys
LI Ping1;WANG Zeng-song2;YE Ying-zhuan2;TANG Jun-rong2;LI Shui-sheng2; ZHANG Yi-Jun2;WANG Cui-ling2;CHEN Zhi-liang1;ZUO Cong-lin3

..............page:1878-1883

Progress in the study of tubulin inhibitors which bind to colchicine-site
LIU Ling;LIU Zong-ying;LI Zhuo-rong

..............page:1892-1899,1949

bian zhe tui jian
luo juan

..............page:1830

Pharmacokinetics of recombinant lysostaphin in burned patients
YANG Fei-fei1;XIONG Yu-qing2;XIA Chun-hua2;MO Yun-jie3;ZHANG Ji-en3; LI Guo-dong3;LU Wan-ying3;HUANG Qing-shan1

..............page:1864-1866,1877

The US generic drug industry:lessons from the first 25 years
Garth Boehm1;YAO Li-xin1;HAN Liang1;2;ZHENG Qiang1;3

..............page:1849-1860

Effects of α-zearalanol on proliferation and differentiation of osteoblast and OPG/RANKL mRNA expression in vitro
LIU Lu1;LI Jian-yu2;WAN Zong-ming3

..............page:1926-1929,1952

Determination of triethanolamine in cream by HPLC-ELSD
WANG Xiao-dong1;LAN Juan2;DI Bin2

..............page:1942-1945

Gas chromatography detection of residual solvents in torasemide
LIU Ming-li;WEI Ning-yi;ZHOU Ying;MA Shuang-cheng

..............page:1872-1873,1883

Significance of mitochondrial toxicity testing in the safety evaluation of innovative drugs
GUO Jia-bin;PENG Hui;WANG Yi-mei;PENG Shuang-qing

..............page:1867-1871